19 November 2013Americas

Cadence wins Ofirmev patent infringement case

Cadence Pharmaceuticals announced on November 14 that the US District Court for the District of Delaware ruled in its favour in its patent infringement suit against Exela Pharma Sciences LLC.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk